EUVIMEDEUVIMED entdecken
Crossref

Inhibiting Bruton's Tyrosine Kinase to Counteract Chemoresistance and Stem Cell‐Like Properties in Osteosarcoma

Hsiao-Chi Tsai, Ming-Yu Lien, Shih-Wei Wang iD, Yi-Chin Fong, Chih-Hsin Tang iD

Environmental Toxicology · 2024

DOI: 10.1002/tox.24368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental Toxicology, 2024. Verfasst von Hsiao-Chi Tsai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine Research, China Medical University Beigang Hospital, Yunlin, Taiwan. Hauptthemen laut MEDLINE: Osteosarcoma, Agammaglobulinaemia Tyrosine Kinase, Drug Resistance, Neoplasm, Neoplastic Stem Cells. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Science and Technology Council (Taiwan), China Medical University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma, a highly aggressive bone cancer, often develops resistance to conventional chemotherapeutics, leading to poor prognosis and survival rates. The malignancy and chemoresistance of osteosarcoma pose significant challenges in its treatment, highlighting the critical need for novel therapeutic approaches. Bruton's tyrosine kinase (BTK) plays a pivotal role in B‐cell development and has been linked to various cancers, including breast, lung, and oral cancers, where it contributes to tumor growth and chemoresistance. Despite its established importance in these malignancies, the impact of BTK on osteosarcoma remains unexplored. Our study delves into the expression levels of BTK in osteosarcoma tissues by data from the GEO and TCGA database, revealing a marked increase in BTK expression compared with primary osteoblasts and a potential correlation with primary site progression. Through our investigations, we identified a subset of osteosarcoma cells, named cis‐HOS, which exhibited resistance to cisplatin. These cells displayed characteristics of cancer stem cells (CSCs), demonstrated a higher angiogenesis effect, and had an increased migration ability. Notably, an upregulation of BTK was observed in these cisplatin‐resistant cells. The application of ibrutinib, a BTK inhibitor, significantly mitigated these aggressive traits. Our study demonstrates that BTK plays a crucial role in conferring chemoresistance in osteosarcoma. The upregulation of BTK in cisplatin‐resistant cells was effectively countered by ibrutinib. These findings underscore the potential of targeting BTK as an effective strategy to overcome chemoresistance in osteosarcoma treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaAgammaglobulinaemia Tyrosine KinaseDrug Resistance, NeoplasmNeoplastic Stem CellsPiperidinesBone NeoplasmsAntineoplastic AgentsAdenineHumansCell Line, TumorCisplatinProtein Kinase InhibitorsPyrimidinesPyrazoles

Stichwörter der Autor:innen

BTK pathwaycancer stem‐like cellschemoresistanceibrutinibosteosarcoma

Substanzen

Agammaglobulinaemia Tyrosine KinasePiperidinesAntineoplastic AgentsibrutinibAdenineCisplatinBTK protein, humanProtein Kinase InhibitorsPyrimidinesPyrazoles

Autor:innen und Institutionen

  • Department of Medicine Research, China Medical University Beigang Hospital, Yunlin, Taiwan.
  • School of Medicine, China Medical University, Taichung, Taiwan.
  • Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
  • Department of Medicine, MacKay Medical College, New Taipei City, Taiwan.
  • School of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Institute of Biomedical Sciences, Mackay Medical College, Taipei, Taiwan.

ORCID-Profile: Shih-Wei Wang, Chih-Hsin Tang

Förderung

  • National Science and Technology Council (Taiwan)
  • China Medical University Hospital

Zitieren

APA

Tsai, H. C., Lien, M. Y., Wang, S. W., Fong, Y. C., & Tang, C. H. (2024). Inhibiting Bruton's Tyrosine Kinase to Counteract Chemoresistance and Stem Cell‐Like Properties in Osteosarcoma. Environmental Toxicology. https://doi.org/10.1002/tox.24368

Vancouver

Tsai HC, Lien MY, Wang SW, Fong YC, Tang CH. Inhibiting Bruton's Tyrosine Kinase to Counteract Chemoresistance and Stem Cell‐Like Properties in Osteosarcoma. Environmental Toxicology. 2024. doi:10.1002/tox.24368

BibTeX
@article{Tsai2024,
  author = {Tsai, Hsiao-Chi and Lien, Ming-Yu and Wang, Shih-Wei and Fong, Yi-Chin and Tang, Chih-Hsin},
  title = {Inhibiting Bruton's Tyrosine Kinase to Counteract Chemoresistance and Stem Cell‐Like Properties in Osteosarcoma},
  journal = {Environmental Toxicology},
  year = {2024},
  doi = {10.1002/tox.24368}
}
Kostenlos starten →